X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1974) 1974
Newsletter (195) 195
Book Review (174) 174
Publication (39) 39
Conference Proceeding (19) 19
Book Chapter (4) 4
Dissertation (3) 3
Report (3) 3
Magazine Article (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
bisoprolol (1311) 1311
index medicus (1231) 1231
humans (1156) 1156
male (784) 784
female (665) 665
middle aged (554) 554
bisoprolol - therapeutic use (536) 536
adrenergic beta-antagonists - therapeutic use (519) 519
aged (466) 466
cardiac & cardiovascular systems (458) 458
adult (396) 396
heart failure (384) 384
heart failure - drug therapy (353) 353
pharmacology & pharmacy (285) 285
treatment outcome (277) 277
carvedilol (251) 251
mortality (243) 243
hypertension (236) 236
bisoprolol - administration & dosage (234) 234
hypertension - drug therapy (234) 234
heart rate - drug effects (228) 228
metoprolol (225) 225
blood pressure - drug effects (213) 213
beta-blockers (205) 205
bisoprolol - pharmacology (203) 203
propanolamines - therapeutic use (197) 197
adrenergic beta-antagonists - pharmacology (184) 184
abridged index medicus (177) 177
adrenergic beta-antagonists - administration & dosage (177) 177
double-blind method (172) 172
cardiac patients (159) 159
research (157) 157
drug therapy (152) 152
medicine, general & internal (149) 149
animals (144) 144
antihypertensive agents - therapeutic use (142) 142
heart failure - physiopathology (142) 142
drug therapy, combination (135) 135
carbazoles - therapeutic use (132) 132
cardiac-insufficiency bisoprolol (132) 132
analysis (130) 130
time factors (122) 122
dose-response relationship, drug (117) 117
heart failure - mortality (116) 116
myocardial-infarction (116) 116
care and treatment (109) 109
metoprolol - therapeutic use (109) 109
adrenergic beta-antagonists - adverse effects (106) 106
atenolol (105) 105
bisoprolol - adverse effects (104) 104
risk factors (102) 102
beta-blocker (99) 99
peripheral vascular disease (98) 98
follow-up studies (97) 97
hypertension - physiopathology (95) 95
aged, 80 and over (93) 93
propanolamines - pharmacology (92) 92
therapy (92) 92
prospective studies (90) 90
randomized controlled trials as topic (86) 86
survival (86) 86
angiotensin-converting enzyme inhibitors - therapeutic use (85) 85
heart rate (84) 84
chronic disease (81) 81
medicine & public health (81) 81
drugs (80) 80
randomized-trial (80) 80
reports (80) 80
medical research (79) 79
cardiology (77) 77
trial (77) 77
double-blind (76) 76
medicine, experimental (74) 74
propanolamines - administration & dosage (74) 74
propranolol (74) 74
rats (74) 74
morbidity (71) 71
guidelines (70) 70
dilated cardiomyopathy (68) 68
electrocardiography (68) 68
management (67) 67
nebivolol (67) 67
arterial hypertension (66) 66
beta blockers (66) 66
clinical trials as topic (66) 66
hemodynamics - drug effects (66) 66
prognosis (66) 66
echocardiography (65) 65
pharmacokinetics (65) 65
chronic heart failure (64) 64
left-ventricular dysfunction (63) 63
cardiovascular (61) 61
chronic heart-failure (61) 61
drug administration schedule (61) 61
adrenergic beta-1 receptor antagonists - therapeutic use (59) 59
heart (59) 59
ventricular function, left - drug effects (58) 58
acute myocardial-infarction (57) 57
antihypertensive agents - administration & dosage (57) 57
cross-over studies (57) 57
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1834) 1834
Russian (126) 126
German (76) 76
French (43) 43
Spanish (27) 27
Polish (16) 16
Chinese (11) 11
Portuguese (11) 11
Czech (10) 10
Japanese (9) 9
Hungarian (7) 7
Turkish (5) 5
Ukrainian (5) 5
Italian (4) 4
Serbian (2) 2
Slovak (2) 2
Danish (1) 1
Dutch (1) 1
Slovenian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


La Revue de medecine interne, ISSN 0248-8663, 06/2017, Volume 38, p. A167-A168
L'atteinte cardiaque au cours de la sclerodermie systemique est classiquement secondaire a une HTAP ou a une atteinte pulmonaire. Cependant, une... 
Diltiazem | Bisoprolol
Journal Article
Archives de pediatrie, ISSN 0929-693X, 07/2016, Volume 23, Issue 7, p. 742
Nous rapportons l'observation d'un enfant de 7ans atteint d'extrasystoles ventriculaires (ESV) nombreuses d'apparence benigne et d'une dysfonction... 
Arrhythmia | Bisoprolol
Journal Article
Archives de pediatrie, ISSN 0929-693X, 07/2016, Volume 23, Issue 7, p. 742
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1016/j.arcped.2016.04.004 
Arrhythmia | Bisoprolol
Journal Article
Journal Article
La Revue de medecine interne, ISSN 0248-8663, 12/2018, Volume 39, p. A115
La granulomatose avec polyangeite (GPA) est une vascularite necrosante systemique, caracterisee par une atteinte inflammatoire des vaisseaux de petit et de... 
Wine | Hypertension | Lysine | Bisoprolol
Journal Article
Journal Article
Journal Article
Chemical Engineering Journal, ISSN 1385-8947, 02/2012, Volume 183, pp. 162 - 171
The oxidative removal of dissolved aqueous bisoprolol (BIS) fumarate, prescribed to treat hypertension, by thermally activated sodium persulfate (Na S O ; SPS)... 
Water treatment | Thermal activation | Persulfate | Bisoprolol | Chemical oxidation
Journal Article
Journal Article
European Journal of Heart Failure, ISSN 1388-9842, 06/2011, Volume 13, Issue 6, pp. 670 - 680
Journal Article
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2011, Volume 105, Issue 1, pp. S44 - S49
Summary Background Chronic obstructive pulmonary disease (COPD) frequently coexists in patients with chronic heart failure (CHF) and is a key factor for beta... 
Pulmonary/Respiratory | Chronic obstructive pulmonary disease | Chronic Heart Failure | Bisoprolol | Carvedilol | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | METOPROLOL | EUROPEAN-SOCIETY | MORBIDITY | RESPIRATORY SYSTEM | TOLERABILITY | DYSFUNCTION | BETA-BLOCKERS | TITRATION | ELDERLY-PATIENTS | ASSOCIATION | Antihypertensive Agents - pharmacology | Forced Expiratory Volume - drug effects | Humans | Carbazoles - administration & dosage | Heart Failure - physiopathology | Antihypertensive Agents - administration & dosage | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Bisoprolol - adverse effects | Pulmonary Disease, Chronic Obstructive - epidemiology | Dose-Response Relationship, Drug | Adrenergic beta-Antagonists - pharmacology | Adrenergic beta-Antagonists - adverse effects | Female | Slovenia - epidemiology | Heart Failure - epidemiology | Adrenergic beta-Antagonists - administration & dosage | Carbazoles - adverse effects | Ventricular Function, Left - drug effects | Stroke Volume - drug effects | Treatment Outcome | Propanolamines - adverse effects | Bisoprolol - administration & dosage | Antihypertensive Agents - adverse effects | Heart Failure - drug therapy | Maximum Tolerated Dose | Aged | Bisoprolol - pharmacology | Propanolamines - administration & dosage | Carbazoles - pharmacology | Propanolamines - pharmacology | Chronic Disease | Pulmonary Disease, Chronic Obstructive - drug therapy | Heart failure | Care and treatment | Lung diseases, Obstructive | Cardiac patients | Index Medicus
Journal Article
European Journal of Clinical Pharmacology, ISSN 0031-6970, 4/2013, Volume 69, Issue 4, pp. 859 - 865
Journal Article